Filing Flows › Organogenesis Holdings (ORGO) › How it makes money
How Organogenesis Holdings (ORGO) makes money
Organogenesis Holdings (ORGO) made $45.5M of revenue in the third quarter 2026 (Q3 2026), -70% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $45.5M | 100.0% |
| Income tax | $8K | 0.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $45.5M | -70% |
| Q2 2026 | $43.8M | -57% |
| Q1 2026 | $37.2M | -57% |
| Q4 2025 | $226M | +78% |
| Q3 2025 | $151M | +31% |
| Q2 2025 | $101M | -22% |
| Q1 2025 | $86.7M | -21% |
From Organogenesis Holdings' 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Organogenesis Holdings make money?
Organogenesis Holdings (ORGO) made $45.5M of revenue in the third quarter 2026 (Q3 2026), -70% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.